Associate Director, Regulatory & Pharmaceutical Affairs (Chief Pharmaceutical Officer Deputy)

About this role

This senior pharmaceutical and regulatory position acts as the trusted right-hand partner (“bras droit”) to the Responsible Pharmacist (RP)/Chief Pharmaceutical Officer (CPO). Working in very close collaboration with the RP/CPO, the role supports the oversight, coordination, and execution of the company’s pharmaceutical responsibilities in France and provides continuity of leadership by acting as Deputy Chief Pharmaceutical Officer when required.

The position combines regulatory affairs, pharmaceutical quality, pharmacovigilance, promotional compliance, product supply oversight, and healthcare compliance. It requires both strategic judgment and strong operational involvement to ensure that the activities of the pharmaceutical establishment—particularly those associated with the exploitant status—are conducted in accordance with French and European requirements.

As a true extension of the RP/CPO, the role is expected to anticipate issues, provide sound recommendations, coordinate sensitive matters, and take ownership of key activities. When deputising for the RP/CPO, the incumbent assumes the relevant pharmaceutical responsibilities associated with the missions set out in Article R.5124-36 of the French Public Health Code. This position is hybrid (onsite and remote working) and will be primarily located at Alnylam France offices in Paris.

Key Responsibilities Participate in cross-functional regulatory initiatives within the affiliate, integrating perspectives from Commercial, Medical Affairs, Market Access, Quality, Supply Chain, Pharmacovigilance, and other relevant functions as assigned Facilitate effective collaboration between Regulatory, Medical, PV, Quality, and Commercial functions to identify and address potential compliance risks and ensure timely escalation and resolution of regulatory matters.

Provide regulatory guidance on product information, promotional and non-promotional materials, medical/scientific communications, and other company information concerning medicinal products, ensuring alignment with approved product information and applicable legal requirements. Lead the regulatory review of promotional documents, as the non-promotional elements (institutional and environmental elements) to ensure that they are non-promotional working in partnership with internal groups and external Regulatory partners if necessary Act as the local French regulatory lead for assigned products, if necessary (ensuring local execution of the global strategy related to centralized procedure presdcription products, and/or development activities related to clinical studies etc.